Clinical Trial Update: Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating the safety and efficacy of raltegravir with abacavir/lamivudine in treatment-naive HIV-infected subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• Isentress (Raltegravir)

Snippet

Sponsor: Denver Infectious Disease Consultants, PLLC | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN